Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 1678
TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM335558(US9737525, Compound MIND4-17-56)
Affinity DataIC50: 750nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333453(US9737525, Compound MIND4)
Affinity DataIC50: 1.70E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333453(US9737525, Compound MIND4)
Affinity DataIC50: 3.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333455(US9737525, Compound MIND4-11)
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333455(US9737525, Compound MIND4-11)
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333458(US9737525, Compound MIND4-20)
Affinity DataIC50: 5.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333460(US9737525, Compound MIND4-22)
Affinity DataIC50: 6.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM50424850(CHEMBL2315467 | US9737525, Compound MIND4-19)
Affinity DataIC50: 7.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333462(US9737525, Compound MIND4A)
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM335557(US9737525, Compound MIND4-17-33)
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333456(US9737525, Compound MIND4-12)
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333461(US9737525, Compound MIND4-23)
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333459(US9737525, Compound MIND4-21)
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333459(US9737525, Compound MIND4-21)
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333454(US9737525, Compound MIND4-2)
Affinity DataIC50: 1.20E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM335554(US9737525, Compound MIND4-17)
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM335555(US9737525, Compound MIND4-17-3)
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM335556(US9737525, Compound MIND4-17-15)
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333464(US9737525, Compound MIND4C)
Affinity DataIC50: 2.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent

TargetNAD-dependent protein deacetylase sirtuin-2(Human)
The General Hospital

US Patent
LigandPNGBDBM333463(US9737525, Compound MIND4B)
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
Go to US Patent